pharma news from FierceHealthcare
News
AstraZeneca asks judge to nullify $215M drug-price lawsuit
Drugmaker AstraZeneca has asked an Alabama judge to nullify a jury verdict that ordered it to pay the state $215 million in damages in a Medicaid drug-price fraud suit. The state's 2005 suit accused Read more...
Pharma gift disclosure law wins Eli Lilly support
While its peers appear to be firmly opposed to such rules, pharmaceutical giant Eli Lilly has decided to support federal legislation that would require drugmakers to disclose payments to doctors. Read more...
ALSO NOTED: Plavix copycat on the rise in Europe; Hospital bills for services to dead patient; and much more...
> Pharma giants Sanofi-Aventis and Bristol-Myers Squibb are preparing to battle a copycat generic to its Plavix brand. Read more...
Trend: Medical schools discourage use of demeaning slang
Getting through medical school is a tough indoctrination into a close-knit fraternity, so it's no surprise that people develop their own culture. One aspect of that culture is the adoption of Read more...
College group urges ban on drug, devicemaker freebies
The association representing U.S. medical colleges has come out with a proposed ban on pharma and device-maker gifts on medical college campuses. The group, the Association of American Medical Read more...
Louisiana MDs win legal battle over patient record disclosure
A group of Louisiana physicians have won their battle to keep their patients' records out of the hands of a pharmaceutical company--though they may face future challenges on the issue. The dispute Read more...
SPOTLIGHT: Survey: Direct-to-consumer pharma ads work
A new study confirms what most of us suspected already: that pharma direct-to-consumer advertising works. According to the study, nearly one-third of Americans ask their doctors about a drug they've Read more...
Who will pay for DTC pharma ad oversight?
Right now, there's a little-watched debate underway on the Hill which could have a meaningful influence on the growth of direct-to-consumer pharma advertising. The question is whether Congress should Read more...
FDA rules on off-label article distribution issued
The FDA may soon be loosening its guidelines for distribution of journal articles discussing unapproved uses of approved drugs and devices, a move which some consumer advocates (and some legislators) Read more...
Merck agrees to pay$650M+ to settle suits
Merck has agreed to pay more than $650 million to settle two whistleblower suits, the U.S. Justice Department has announced. One of the suits claimed that the pharma paid providers to use its Read more...
Get more pharma coverage at:
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies